Somnomed Limited (AU:SOM) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
SomnoMed Limited has undergone significant changes with the appointment of co-CEOs Karen Borg and Amrita Blickstead, who have driven growth and operational improvements. The company reported FY24 revenue of $91.7 million and has focused on strengthening its manufacturing capabilities to meet rising product demand. With recent FDA clearance of its innovative Rest Assure® device, SomnoMed aims for continued growth and improved financial stability.
For further insights into AU:SOM stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- ‘Load Up Despite California’s EV Noise,’ Says Daniel Ives About Tesla Stock
- M&A News: Paramount (PARA) Turned Down Apollo Global Management Seven Times
- Ford (NYSE:F) Calls for EV Incentives in the United Kingdom
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
